Psychemedics Corporation (PMD)
NASDAQ: PMD · IEX Real-Time Price · USD
2.300
-0.030 (-1.29%)
At close: Jul 19, 2024, 12:00 AM
2.230
-0.070 (-3.04%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Psychemedics Employees
Psychemedics had 116 employees as of December 31, 2023. The number of employees decreased by 17 or -12.78% compared to the previous year.
Employees
116
Change (1Y)
-17
Growth (1Y)
-12.78%
Revenue / Employee
$186,172
Profits / Employee
-$38,431
Market Cap
13.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Addex Therapeutics | 23 |
Avalo Therapeutics | 19 |
NeuroSense Therapeutics | 18 |
GeoVax Labs | 17 |
QT Imaging Holdings | 14 |
Kiora Pharmaceuticals | 12 |
XTL Biopharmaceuticals | 7 |
PMD News
- 4 weeks ago - Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing - GlobeNewsWire
- 2 months ago - Psychemedics Corporation Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Psychemedics Corporation Reports 2023 Financial Results - GlobeNewsWire
- 4 months ago - Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider - GlobeNewsWire
- 7 months ago - Psychemedics Corporation Announces Relocation of Headquarters to Dallas, Texas - GlobeNewsWire
- 8 months ago - Psychemedics Corporation Appoints Daniella Mehalik as VP - Finance - GlobeNewsWire
- 9 months ago - Psychemedics Corporation Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 9 months ago - Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen - GlobeNewsWire